Slides from the recent REC event 'How to Work in Europe and Beyond'

1. How to Workin Europe andBeyond
24th September 2015
ChemicalIndustriesAssociation

2. Agenda
Mark Treherne – Chief Executive of UKTI
Life Sciences Organisation
Ajay Patel - Director of Recruitment &
Staffing Mid Europe Region, MSD
Stuart Marquis, Liberty Bishop
New Scientist Jobs: Sponsors of the event
Panel Discussion
Closing remarks and depart

3. 3

4. Unlock Your Global Business Potential: The UK Life
Science Offer
4
THE UK HAS THE MOST OPEN AND BUSINESS-ORIENTATED ECONOMY OF EUROPE, WITH
THE MOST FLEXIBLE LABOUR MARKETS, AND THE LEAST RESTRICTIVE SYSTEMS
Unlock Your Global Business Potential:
The UK Life Science Offer
REC Life Sciences Event
24th September, 2015

5. Unlock Your Global Business Potential: The UK Life Science Offer
Government’s Commitment to the Life
Science Sector
“In December 2011 I made a firm commitment to re-establish the
UK's global leadership in the life science sector, announcing the
Government's ten-year Strategy for UK Life Sciences.”
“By more closely integrating the UK's unique strengths, I believe
that we can improve healthcare for patients, attract new investment
to the UK, and create new jobs and business opportunities in an
increasingly competitive and international industry.”
David Cameron
Prime Minister
5
The Strategy makes the most of the UK’s core strengths:
 Basic science in universities
 Translational and clinical research
 Industry
 The National Health Service (NHS)

6. Unlock Your Global Business
Potential: The UK Life Science Offer
The UK Ecosystem: Connect, Research,
Develop, Validate, and Export
This increasingly integrated ecosystem
is underpinned by a:
 Supportive business environment
 Open and flexible regulatory framework
 Simplified industry access points

7. Unlock Your Global Business Potential: The UK Life Science Offer
UK Science: A Rich Heritage, Vibrant Research
Base, and Investments for the Future
The UK has a rich heritage of life science discovery that has transformed
scientific knowledge and continues to unlock clinical and commercial
opportunities
77 Nobel Prizes and counting for contributions to biomedical science: from the building
blocks of the new genomic age to the secrets of cells, to the physics that underpin magnetic
resonance imaging (MRI)
World-class science + protected science budget
Major research funding from the Medical Research Council and research charities like
the Wellcome Trust and Cancer Research UK
In 2012, significant investment were made in next-gen science including genomics,
synthetic biology, bioinformatics, and stem cells and regenerative medicine
Support from the Technology Strategy Board and the Biomedical Catalyst to
translate science into new products and services
Present
Future
Past

8. Unlock Your Global Business Potential: The UK Life Science Offer
Building a Collaborative Research Ecosystem:
Active Partnership
The UK actively encourages research partnerships between academia, industry, and the NHS:
 In Northern Ireland, Northern Ireland’s
Connected Health and Prosperity Action
Plan ensures cross sectorial support for
health & social care R&D, innovation and
widespread deployment of healthcare
technologies.
 In Wales, the National Institute for
Social Care and Health Research
Academic Health Science
Collaboration maximises links between
health boards , trusts, universities and
industry to facilitate high quality
research and improve healthcare.
 Scotland, the Scottish
Academic Health Sciences
Collaboration facilitates
partnerships between Scottish
universities and health
boards. This offers industry a
coordinated system to
contract and cost research
studies across Scotland.
 In England, five Academic
Health Science Centres open
up routes to market,
supporting the development of
new therapies and techniques

9. Unlock Your Global Business Potential: The UK Life Science Offer
Life Sciences Organisation – Recording Increased
Results
LSO is tasked each year with delivering on key investment projects and targets and
focuses on bringing value adding investment to the UK.
There has been a consistent increase in inward investment over the past three years.
Results for 2014/15:
 UK confirmed as the #1 destination for FDI in Europe
 LSO and our partners helped more than 180 businesses invest in the UK, creating more
than 5,500 new jobs and more than £2.2bn in new investment
 20% of projects were linked to European, international or global headquarters functions
 25% were linked to manufacturing
 Nearly half involved R&D
 From inception to March 15: £3.7bn investment and over 11,000 new jobs
This year, LSO will continue to focus on value-adding inward investment, attracting
investment in priority subsectors and project themes, and enhancing our emphasis
on Export Oriented FDI.
Sources: UKTI Annual Inward Investment Report and UKTI LSO data

10. • Strong confidence in UK market is reflected in recent
IPO activity reaching £408 million in 2014, with a
further two IPOs in 2015
• Good stock market performance of new entrants,
including 247% share gain by 4D Pharma since its IPO,
helping to highlight the benefits of investing in the
sector
• Increase in exits (via IPO and trade sales) have
created a 10 year record in venture funding:
investment in 2014 is up 71% to $430 million (2013:
$251 million)
• UK is holding its own against the US and
outperforming Europe in the past five years for
venture funding
Public Markets
Source: BIA

11. Top 5 Public Investments 2013-2015
Source: EvaluatePharma® May 2015

12. UK Biotech VC annual data by round 2010-2014
Source: EvaluatePharma® May 2015

13. • UK Life science has recovered as an investment class
Why invest in the UK Life Science Sector?
Source: Venture Market Index

14. • Historical situation:
Who invests in the UK Sector?
Redrawn from Ford & Nelsen “The view beyond venture capital” Nature Biotech Dec 13

15. • Current situation:
Who invests in the UK Sector?
Redrawn from Ford & Nelsen “The view beyond venture capital” Nature Biotech Dec 13

16. • Need to understand the investor imperatives
• Pure financial
• Purely strategic
• Somewhere between the two
• It is possible to make money in the UK but
history suggests most UK funds have not
beaten alternative investment classes to date
• Government support can support investment
• The UK may be the largest, most dynamic
market after the US
Why invest in the UK Life Science Sector?

17. How is the investment process changing?
Note: CVC and VC investments by stage (% of companies, 2007 – 2011) All Sectors.

18. Unlock Your Global Business
Potential: The UK Life Science Offer
How UK Trade & Investment (UKTI) Can Help
Your Business
Our practical help and advice is free and confidential
UKTI’s professional trade and industry advisers operate in the UK alongside a global network of
experts based in all British diplomatic offices overseas.
UKTI can:
 Provide tailored information on the UK offer and capabilities that match your business needs
 Support your business journey to invest in and grow in the UK
UKTI’s Life Sciences Organisation (LSO)
The LSIO is here to help your business navigate the opportunity to partner with and invest in the UK
and to connect you to wider UK life science community
For further details on the LSO and the UK life sciences offer for industry, visit:
www.ukti.gov.uk/lifesciences

19. Unlock Your Global Business Potential: The UK Life
Science Offer
19
THE UK HAS THE MOST OPEN AND BUSINESS-ORIENTATED ECONOMY OF EUROPE, WITH
THE MOST FLEXIBLE LABOUR MARKETS, AND THE LEAST RESTRICTIVE SYSTEMS
Thank you
People Matter!

20. MSD
REC Conference
September 24th 2015
20

21. MSD Recruitment & Staffing
Agency Consulting Outsourcing In HouseEducation
Ajay Patel
Associate Director, Recruitment & Staffing Mid Europe
Started career in Pharma / Science recruitment
Corporate, Global and Country level recruitment
Manufacturing, Research, Development, Global Functions
Agency Consulting, RPO (outsourcing), in house recruitment
BSc Physics
with Astrophysics
2001 2009 2014

22. MSD Recruitment & Staffing
MSD Sourcing Challenges
MSD Sourcing Challenges
External macro environment is changing:
Demographics quickly evolving.
Governments address demands of > cost of healthcare.
Our customers and their needs are changing.
MSD is transforming:
Launching in new therapy areas, e.g. Oncology, HCV.
We need to hire new / rare skillsets
to enable transformation
to compete in new therapy areas.
Talent Acquisition is changing:
There is a very real “War for Talent” in the pharma industry and we are not currently set
up to compete effectively.

23. MSD Recruitment & Staffing
MSD Europe & Canada Hiring
Direct Applications
44%
Temp to Perm
20%
Agency
10%
Employee Referral
3%
External DB Search
6%
Social Media Search
6%
Advertising
7%
Social Media Advertising
4%
MSD Europe & Canada
2015 Number of External Hires per annum = Approx. 1200
Source Mix

24. MSD Recruitment & Staffing
What % of niche external candidates can MSD see?
MSD Careers website advertising
“Post and Pray”
Taleo Database Mining
HM / Employee Referrals
Social Media Soucing
LinkedIn, Xing, Facebook, Blogs
Advanced Boolean Search
Telephone Networking / Referrals
10%25%60% 45%80%
%Visibilityofallcandidatesinmarketplace

25. MSD Recruitment & Staffing
MSD Business Critical Needs in 2016
Functional Area
Medical Affairs
Market Access
Marketing / Commercial
Supply Chain
Planned Launches
Oncology
HEP C
HIV
“Future Leaders”

26. MSD Recruitment & Staffing
EUCAN Sourcing Hub
Launch of MSD EUCAN Sourcing Hub
EUCAN region volume is approx. 1200 external hires / annum
• RPO Sourcing Hub focus on 375 reqs / annum (prioritize critical skillsets)
• Build basic agency capability in house with “Recruiter / Sourcer model”
5 x RPO Sourcers
0.5 x RPO Manager
Offsite in Warsaw, Poland
RPO Resources
MMD
ONCO
1. Longlisting
2. Longlisting + Qualification
3. Longlisting + Qualification + Interview
4. Market Intelligence Reports
RPO Sourcing “Packages”

27. MSD Recruitment & Staffing
There is still a need for strong agencies …
Why Would I Engage A Recruitment Agency?
Credibility in sourcing strategy presented to Hiring Manager
Bringing Market Intelligence to the conversation
Security of knowing a trusted Agency will deliver in a specific timeframe
Pipelining talent for confidential / business critical roles
Fast Access to existing database of candidate relationships
“Local Knowledge” in a specific country based market
Capacity extension for existing in house recruiter team
Business critical projects / growth strategy

28. MSD Recruitment & Staffing
There is a need for strong agencies in the EU…
Observations / Opportunities in Europe
European Agency market is relatively empty in many key markets
There is a gap for “Local” credible specialists in niche areas
Some UK Agencies setting up local offices in EU
Language skills are important!
Remote UK Recruiters:
Hard to pick to good from the bad
UK Agencies are seen as “aggressive”
UK Agencies employ varied marketing strategies
In house team will actively avoid calls from UK numbers!
An Agency Brand is only as good as your individual Recruiter servicing the Client

29. Good Afternoon… I’m Stuart Marquis from
… with thanks to you for your time, and to
Thursday 24th September 2015

30. Who are Liberty Bishop?
We provide contractors with Umbrella and Limited Company services in the UK, as
well as providing payroll solutions for contractors working internationally.
• Established in 1995 – We have an in-depth understanding of your needs and
those of your contractors
• Compliance – We ensure that all areas of compliance are adhered to in order to
reduce risk to you, your clients, and your candidates
• We are “people NOT portals” and offering a highly personal service

31. Topic discussion:
“International Contractor Compliance”

32. Some General Methodological Principles
Correct Understanding of the 183 Day Ruling:
• Refers to the issue of tax residency, but that’s not the issue of primary
importance
• Difference between non-resident and resident largely irrelevant with respect to
tax due on local income
• Primary driver for where tax is due = where the work is being carried out

33. Some General Methodological Principles (continued)
The A1 route and its potential limitations:
• Problematic for one-man-band Ltd company contractors
• Payroll providers relying on this model unable to assist a wider spectrum of
workers

34. International Solutions
We’ll now cover a brief overview for the following locations:
France
(60-73%
retention
Germany
(50-64%)
retention
The
Netherlands
(60-65%
retention)
Ireland
50-65%
retention
Sweden (50-68% retention)

35. Germany
• Labour leasing license (AUG)
• German ID number and Tax Card
• Health Insurance requirement
• Wage Tax and Social Security

36. The Netherlands
• Dutch Chamber of Commerce
• Dutch wage Tax and Social Security
• 30% Ruling allowance
• Collective Labour Agreement
• G-Accounts

37. Sweden
• Swedish ID Number
• SA Tax
• SINK Tax

38. Ireland
• PPS number (Personal Public Service)
• Irish Income Tax Card
• PAYE and PRSI (Pay Related Social Insurance)

39. France
• PPS number (Personal Public Service)
• Irish Income Tax Card
• PAYE and PRSI (Pay Related Social Insurance)

40. Concluding Remarks
• Local registration from day one
• Deduction of local tax and social security, except
where A1 applies

41. I would just like to say…
Any Questions please feel free to ask…
For all the latest news & updates
please follow:

43. Panel Discussion

44. Thank you for coming
Next event: Scale up for High Skills, 10th November,
REC Offices